ArticleCancers2022

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy.

Viola Salvestrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.